上海赛伦生物技术股份有限公司2025年第一次临时股东大会决议公告

Group 1 - The core point of the announcement is the resolution of the first extraordinary general meeting of shareholders of Shanghai Sailun Biotechnology Co., Ltd. held on August 11, 2025, which included the approval of significant changes to the company's governance structure and operational scope [1][2][4]. Group 2 - The meeting was held at the company's headquarters in Shanghai, with all board members and supervisors present, ensuring a quorum for decision-making [2][3]. - Two main resolutions were passed: the cancellation of the supervisory board and amendments to the company's articles of association, which were approved by more than two-thirds of the voting rights held by shareholders present [4][5]. - The meeting was legally validated by the Shanghai Jintiancheng Law Firm, confirming that all procedures and voting results complied with relevant laws and regulations [5].